Financhill
Buy
59

CME Quote, Financials, Valuation and Earnings

Last price:
$238.57
Seasonality move :
2.09%
Day range:
$235.60 - $240.31
52-week range:
$190.70 - $249.02
Dividend yield:
4.13%
P/E ratio:
25.08x
P/S ratio:
14.20x
P/B ratio:
3.05x
Volume:
2.9M
Avg. volume:
2.4M
1-year change:
13.02%
Market cap:
$86B
Revenue:
$5.6B
EPS (TTM):
$9.51

Earnings Data

Next earnings date for CME
Feb 14
2025
Most recent earnings per share
$2.50
Missed by $0.15
(Oct 23/2024)
Consensus Estimate
$2.65
(Oct 23/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CME Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/14/2025 Q4 $1.5B -- -- $2.48 --
10/23/2024 Q3 $1.6B $1.6B $2.50 $2.65 -$0.15
07/24/2024 Q2 $1.5B $1.5B $2.42 $2.53 -$0.11
04/24/2024 Q1 $1.5B $1.5B $2.35 $2.45 -$0.10
02/14/2024 Q4 $1.4B $1.4B $2.24 $2.28 -$0.04
10/25/2023 Q3 -- -- $2.06 $2.22 -$0.16
07/26/2023 Q2 -- -- $2.14 $2.19 -$0.05
04/26/2023 Q1 -- -- $2.43 $2.38 $0.05
02/08/2023 Q4 -- -- $1.75 $1.88 -$0.13
10/26/2022 Q3 -- -- $1.87 $1.94 -$0.07
07/27/2022 Q2 -- -- $1.82 $1.93 -$0.11
04/28/2022 Q1 -- -- $1.95 $2.00 -$0.05
02/09/2022 Q4 -- -- $1.71 $1.64 $0.07
10/27/2021 Q3 -- -- $2.58 $1.55 $1.03
07/28/2021 Q2 -- -- $1.42 $1.61 -$0.19
04/28/2021 Q1 -- -- $1.60 $1.76 -$0.16
02/10/2021 Q4 -- -- $1.18 $1.36 -$0.18
10/28/2020 Q3 -- -- $1.15 $1.44 -$0.29
07/29/2020 Q2 -- -- $1.40 $1.64 -$0.24
04/29/2020 Q1 -- -- $2.14 $2.21 -$0.07
02/12/2020 Q4 -- -- $1.31 $1.55 -$0.24
10/30/2019 Q3 -- -- $1.78 $1.75 $0.03
07/31/2019 Q2 -- -- $1.43 $1.76 -$0.33
05/01/2019 Q1 -- -- $1.39 $1.60 -$0.21
02/14/2019 Q4 -- -- $1.09 -- --
10/25/2018 Q3 -- -- $1.21 -- --
07/26/2018 Q2 -- -- $1.66 -- --
04/26/2018 Q1 -- -- $1.76 -- --
02/01/2018 Q4 -- -- $8.63 -- --
10/26/2017 Q3 -- -- $0.91 -- --
08/01/2017 Q2 -- -- $1.22 -- --
04/27/2017 Q1 -- -- $1.18 -- --
02/02/2017 Q4 -- -- $1.10 -- --
10/27/2016 Q3 -- -- $1.39 -- --
07/28/2016 Q2 -- -- $0.95 -- --
04/28/2016 Q1 -- -- $1.09 -- --
02/05/2016 Q4 -- -- $0.86 -- --
10/29/2015 Q3 -- -- $1.06 -- --
07/30/2015 Q2 -- -- $0.78 -- --
04/30/2015 Q1 -- -- $0.98 -- --
02/05/2015 Q4 -- -- $0.91 -- --

CME Group Earnings Questions

  • How Much did CME Group Generate in Revenue Last Quarter?

    CME Group reported $1.6B worth of top line sales in its most recent quarter.

  • Did CME Group Beat Earnings Last Quarter?

    CME Group announced earnings per share of $2.50 which represents a miss of analyst forecast a $2.65 per share.

  • Is CME Group Profitable?

    CME Group reported $1.4B that represents $3.79 per share over the last quarter.

  • What is the Analyst Consensus for CME Group EPS Next Year?

    CME Group's earnings are forecast to grow from $8.86 per share to $9.25 per share next year representing an increase of 15.33%.

  • When is CME Group's Earnings Date?

    CME Group's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock